NLM Gateway
A service of the U.S. National Institutes of Health
Your Entrance to
Resources from the
National Library of Medicine
    Home      Term Finder      Limits/Settings      Search Details      History      My Locker        About      Help      FAQ    
Skip Navigation Side Barintended for web crawlers only

Hormonal Contraceptive use and incidence of Herpes Simplex virus Type 2 among women in Thailand.

Brown JM, Rungruengthanakit K, Rugpao S, Cornelisse PG, Padian N, Morrison C; International Conference on AIDS (15th : 2004 : Bangkok, Thailand).

Int Conf AIDS. 2004 Jul 11-16; 15: abstract no. ThPeC7385.

University of California, San Francisco, San Francisco, CA, United States

Background: Herpes Simplex Virus type 2 (HSV-2) is an indicator of sexual risk behavior and is an important facilitating factor for HIV transmission. Animal models suggest that sex hormones, estrogen and progesterone, may influence the risk of HSV-2 acquisition. The objective of this analysis was to measure the prevalence and incidence of HSV-2 among women in Thailand, and assess the independent effect of common hormonal contraceptive (HC) methods, namely Depo-Provera and combined oral contraceptives, on the incidence of HSV-2 in this population. Methods: Between 1999-2002, we recruited 1,574 HIV-uninfected women aged 18-35 into a 2-year prospective study of HC use and HIV. Participants were recruited from family planning and STD clinics. At baseline and quarterly, we used a standardized questionnaire to collect socio-demographic characteristics, contraceptive history, and sexual behavior, and performed a physical (including pelvic) exam, and tested sera for HSV-2 antibod ies. Multivariate logistic regression analysis was used to evaluate independent predictors of HSV-2 incidence. Results: Overall HSV-2 prevalence was high at baseline (38%) and ranged from 14% among women under 20 years of age to 49% among women >30 years of age. Among women without HSV-2 at baseline, 67 (7.7%) acquired HSV-2 during the study period. In multivariate analyses controlling for woman's age, partner's age, and condom use, women reporting more than one sex partner were at increased risk for HSV-2 acquisition (OR=4.79, 95% CI (1.7,13.3)) while women using HC (e ither Depo-Provera or combined oral contraceptives) were significantly less likely to acquire HSV-2 compared to women not using HC (OR=0.49, 95% CI (0.27,0.88)). There was no difference between the effect of Depo-Provera and the effect of COC on HSV-2 incidence. Conclusions: This analysis indicates that the prevalence and incidence of HSV-2 is high in this population. Women using HC were significantly less likely to acquire HSV-2 compared to women not using HC.

Publication Types:
  • Meeting Abstracts
Keywords:
  • Acquired Immunodeficiency Syndrome
  • Contraceptive Agents
  • Female
  • HIV Infections
  • HIV Seropositivity
  • Herpesvirus 2, Human
  • Humans
  • Incidence
  • Medroxyprogesterone 17-Acetate
  • Prevalence
  • Prospective Studies
  • Sexual Behavior
  • Sexual Partners
  • Thailand
  • epidemiology
  • utilization
Other ID:
  • GWAIDS0036948
UI: 102281164

From Meeting Abstracts




Contact Us
U.S. National Library of Medicine |  National Institutes of Health |  Health & Human Services
Privacy |  Copyright |  Accessibility |  Freedom of Information Act |  USA.gov